PSA screening and deaths from prostate cancer after diagnosis--a population based analysis. Prostate 73, 1365-1369.Wachtel MS, Nelius, T, Haynes AL, Dahlbeck S and de Riese W: PSA screening and deaths from prostate cancer after diagnosis ‑ a population bases analysis. Prostate 73: ...
In this preliminary descriptive report from an ongoing randomized clinical trial, 1 additional high-grade cancer per 196 men and 1 low-grade cancer per 909 men were detected among those randomized to be invited to undergo a...
2) Could produce false-positive or false-negative results Another controversy surrounding prostate cancer screening using the PSA test is that it may give false-positive or false-negative results for prostate cancer. What that means is you may have an elevated PSA level, but no cancer is actuall...
Increased PSA Screening Linked to Lower Risk of Advanced Prostate Cancer at Diagnosis and Death From the Disease in Younger African American Patients. Alexandria, VA: 2021 American Society of Clinical Oncology Annual Meeting; May 19, 2021.https://www...
Third, screening was less intensive than in the ERSPC or PLCO trials, aiming to reduce overdetection. The higher age, Gleason grade, and cancer stage at diagnosis in the CAP trial’s intervention group compared with in the ERSPC and PLCO trials reflect adherence to the low-intensity strategy....
Using the PSA Blood Test After Prostate Cancer Diagnosis Your doctor can get helpful information from a PSA test even after a prostate cancer diagnosis. For instance, your doctor can use your PSA levels for: Active surveillance.This is an option for people with prostate cancer who may not need...
Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2021, 79, 243–262. [Google Scholar] [CrossRef] [PubMed] Ost, P.; Reynders, D.; Decaestecker, K.; Fonteyne, V.; Lumen, N.; De Bruycker, A.; Lambert, B.; Delrue, L.; Bultijnck, R.; Claeys,...
55 to 69: Screening if your doctor suggests Over 70 or less than a 10-15 year life expectancy: No screening The U.S. Preventive Services Task Force says: Men aged 55 to 69 who have prostate cancer risks may need testing. If your doctor thinks you might have prostate cancer based on ...
Genetically adjusted PSA levels for prostate cancer screening ArticleOpen access01 June 2023 Applying a genetic risk score for prostate cancer to men with lower urinary tract symptoms in primary care to predict prostate cancer diagnosis: a cohort study in the UK Biobank ...
PCa incidence increased by 10% in the screening arm as compared to the control arm (RR = 1.10; 95%CI = [1.04–1.16], P = 0.001). The risk classification at time of diagnosis is described in Table 3, and shows similar percentages of each risk category in men randomised to the ...